A semaglutide starting price can mean a complete compounded supply, a first-month discount or the monthly equivalent of a year paid upfront. Those are different fina
A semaglutide starting price can mean a complete compounded supply, a first-month discount or the monthly equivalent of a year paid upfront. Those are different financial decisions. This index records five named offers with the payment conditions that make the numbers useful.
Injection Index does not assign a universal cheapest provider from incomplete quantities or different formulations. The current official captures distinguish recurring prices, promotions and annual commitments. A compounded preparation remains different from FDA-approved branded semaglutide, and the clinician should explain why the actual prescription is appropriate.
Compounded semaglutide $99/mo; tirzepatide $149/mo; no membership fee
A stated monthly compounded-medicine price, with important prescription and refund checkpoints.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Compounded semaglutide $69; tirzepatide $119; promotion and term conditions
SnagRx advertises low flat monthly prices, but longer subscription terms and its medically limited refund rule qualify the cancellation headline.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
GLP-1 from $89; GLP-1 plus GIP from $149; selected preparation and terms apply
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Semaglutide then $212 per four-week supply; tirzepatide $99 then $280
Enhance.MD publishes distinct introductory and continuing rates, including $49 then $212 for its semaglutide plan; combined-drug marketing is not approval or superiority evidence.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Semaglutide monthly; $99/mo equivalent annual commitment billed $1,188 upfront
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Compare the selected semaglutide preparation, prescribed amount, supply duration and total payment. Keep four weeks separate from a calendar month, and do not treat an annual equivalent as a monthly charge. Consultation, supplies and delivery need their own confirmation where inclusion is unclear. The useful question is what the patient will actually pay now and at renewal. Read the related care guide for a wider treatment discussion.
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. The named semaglutide page provides a clear starting rate and no-membership claim. The actual dispensed amount and repeat-order terms still need confirmation before it becomes a like-for-like price comparison.
CoreAge’s current product pages list compounded semaglutide at $99 per month and compounded tirzepatide at $149, with no membership fee and free delivery if prescribed. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
Read the full CoreAge Rx review to compare the care pathway, prescription and recurring order.
SnagRx describes a clinician-reviewed compounded supply with a patient portal for refills. Its marketing separates no-membership pricing from selected subscription discounts. The product and pharmacy remain individualized prescription facts, while its prominent promotional price needs a term and renewal check. The low promotion is worth understanding, but term discounts and medically limited refunds matter alongside it. Confirm whether the selected checkout is monthly or subscribe-and-save, and what charge follows the current promotional offer.
SnagRx currently promotes compounded semaglutide at $69 and tirzepatide at $119 per month, with medication, supplies, doctor review and free shipping described as included. It distinguishes month-to-month cancellation from subscribe-and-save term discounts. Sales are generally final, with unused-term refunds tied to medical ineligibility. Confirm promotion eligibility, selected term, quantity and renewal before treating the floor as guaranteed indefinitely.
Read the full SnagRx review to compare the care pathway, prescription and recurring order.
AltRx’s self-pay pathway includes a medical review and pharmacy fulfillment when appropriate. The page names independently operated pharmacy partners and distinguishes its compounded offers from branded product listings. A low promotional rate does not establish equivalent outcomes or FDA approval of the compounded preparation. The page distinguishes GLP-1 from GLP-1 plus GIP and branded products. Ask which actual preparation the lower offer concerns and retain its clinical and fulfillment inclusion instead of borrowing a price across categories.
AltRx currently displays a GLP-1 offer from $89 per month and GLP-1 plus GIP from $149, with separate branded product prices. Its membership includes consultation, prescription fulfillment when appropriate, shipping and clinician support; no separate membership fee is advertised. Confirm the actual compound, dispensed quantity and recurring terms. Self-reported member outcomes are not independent clinical evidence.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
Enhance.MD connects clinician-directed compounded programs with a four-week supply, support and stated laboratory inclusion. Its semaglutide and tirzepatide offers have separate introductory and later prices. The different program names and supply periods should remain visible when the ongoing care budget is compared. The initial semaglutide price is materially lower than the ongoing figure. Both should stay visible, with the four-week supply unit preserved so a long-term budget does not mistake the first charge for the regular plan.
Enhance.MD currently lists compounded semaglutide at $49 for the first month and $212 afterward; tirzepatide is $99 initially and $280 afterward. Its cards describe four weeks of medication, provider support and metabolic labs every six months. Confirm shipment, subscription and supply terms: four weeks is not a calendar month, and a low initial charge is not the ongoing budget.
Read the full Enhance.MD review to compare the care pathway, prescription and recurring order.
Trimi describes individualized compounded semaglutide and tirzepatide prescriptions with provider review, supplies and shipment. It offers materially different annual and monthly payment commitments. The named pharmacy pathway helps identify what to ask, while regulatory status and clinical rationale still need separate consideration. The annual plan’s low equivalent requires a much larger upfront commitment. Compare that cash requirement with the monthly option, not just the unit number, especially when a first prescription’s tolerance and continuity remain uncertain.
Trimi’s current compounded semaglutide choices are $175 month-to-month or a $99 monthly equivalent on a twelve-month commitment billed $1,188 upfront. Tirzepatide is $235 monthly or $125 equivalent with $1,500 upfront. It lists provider review, supplies and shipping with no membership fee. Confirm selected term, actual amount supplied and refund rules; the annual equivalent is not a monthly payment.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
Obtain a complete quotation for the actual prescription and supply before calling any plan the cheapest for the patient. A lower first bill, smaller unit price and lower yearly equivalent answer different questions. Keep cancellation and refund terms visible, particularly before a prescription is prepared.
FDA cautions that compounded GLP-1 products are not approved and that dosing errors and product-quality concerns have been reported. Do not transfer instructions between vials or use an internet syringe conversion. The pharmacist and prescriber should resolve an unclear label before use.
Continue with Cheapest tirzepatide injection plans: five offers beyond the lowest monthly number and Best annual GLP-1 plan comparisons and monthly alternatives: five payment choices.
Explore the review directory and full cost table to compare the details of another offer.
Official public information reviewed October 1, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.
Build a useful comparison from the next invoice, not the smallest number on the page.
Read the guide →The ingredient name is the beginning of the medicine discussion, not the complete answer.
Read the guide →Bring the information that turns an online assessment into a useful medical discussion.
Read the guide →